Premium
Medpace Holdings Inc (MEDP)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | -16,35k | 5,09M | Derivative Exercise and Sale | 138,87 - 450,00 | 20,34k | - |
| 2026-04-24 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | 3,50k | 486,05k | Derivative Exercise and Retained Stock | 138,87 | 20,34k | 20,78% |
| 2026-04-24 | Mr. Kevin M. BradyCFO & Treasurer | 7,00k | 972,09k | Derivative Exercise and Retained Stock | 138,87 | 12,83k | 120,07% |
| 2026-03-31 | Mr. Cornelius Patrick McCarthyIndependent Director | 29,00 | 0,00 | Derivative Exercise and Retained Stock | - | 10,32k | 0,28% |
| 2026-03-31 | Mr. Robert O. KraftIndependent Director | 33,00 | 0,00 | Derivative Exercise and Retained Stock | - | 922,00 | 3,71% |
| 2026-03-31 | Mr. Brian T. CarleyIndependent Director | 36,00 | 0,00 | Derivative Exercise and Retained Stock | - | 32,79k | 0,11% |
| 2026-03-18 | Ms. Susan E. BurwigExec. VP of Operations | 12,00k | 2,00M | Derivative Exercise and Retained Stock | 166,73 | 70,48k | 20,52% |
| 2026-03-17 | Mr. Jesse J. GeigerInitié | -31,71k | 10,03M | Derivative Exercise and Sale | 138,87 - 455,30 | 15,00k | - |
| 2026-02-17 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | 3,50k | 486,05k | Derivative Exercise and Retained Stock | 138,87 | 16,84k | 26,23% |
| 2026-02-13 | Mr. Brian T. CarleyIndependent Director | 6,47k | 355,90k | Derivative Exercise and Retained Stock | 54,99 | 32,75k | 24,63% |
| 2026-02-13 | Ms. Susan E. BurwigExec. VP of Operations | 10,98k | 1,19M | Derivative Exercise and Retained Stock | 107,93 | 58,48k | 23,12% |
| 2025-12-31 | Mr. Cornelius Patrick McCarthyIndependent Director | 49,00 | 0,00 | Derivative Exercise and Retained Stock | - | 10,30k | 0,48% |
| 2025-12-31 | Mr. Robert O. KraftIndependent Director | 56,00 | 0,00 | Derivative Exercise and Retained Stock | - | 889,00 | 6,72% |
| 2025-12-31 | Mr. Brian T. CarleyIndependent Director | 62,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,28k | 0,24% |
| 2025-12-05 | Ms. Susan E. BurwigExec. VP of Operations | 10,00k | 1,08M | Derivative Exercise and Retained Stock | 107,93 | 47,50k | 26,67% |
| 2025-12-03 | Dr. August James TroendleCEO, President & Chairman | -668,00 | 394,58k | Vente | 590,69 | 5,38M | -0,01% |
| 2025-12-02 | Ms. Susan E. BurwigExec. VP of Operations | 10,00k | 1,08M | Derivative Exercise and Retained Stock | 107,93 | 37,50k | 36,36% |
| 2025-12-01 | Dr. August James TroendleCEO, President & Chairman | -28,88k | 17,11M | Vente | 590,47 - 593,25 | 5,38M | -0,53% |
| 2025-11-26 | Dr. August James TroendleCEO, President & Chairman | -56,48k | 34,07M | Vente | 593,46 - 606,88 | 5,41M | -1,03% |
| 2025-11-24 | Dr. August James TroendleCEO, President & Chairman | -101,42k | 61,97M | Vente | 607,78 - 615,52 | 5,47M | -1,82% |
| 2025-11-24 | Ms. Susan E. BurwigExec. VP of Operations | -20,00k | 12,18M | Vente | 609,15 | 27,50k | -42,11% |
| 2025-11-21 | Mr. Kevin M. BradyCFO & Treasurer | -3,00k | 1,27M | Derivative Exercise and Sale | 166,73 - 590,35 | 5,83k | - |
| 2025-11-21 | Mr. Kevin M. BradyCFO & Treasurer | -170,00 | 0,00 | Other Disposition | - | 5,83k | -2,83% |
| 2025-11-20 | Dr. August James TroendleCEO, President & Chairman | -28,69k | 17,03M | Vente | 592,18 - 598,49 | 5,57M | -0,51% |
| 2025-11-18 | Dr. August James TroendleCEO, President & Chairman | -31,05k | 18,38M | Vente | 590,84 - 592,07 | 5,60M | -0,55% |
| 2025-11-14 | Mr. Robert O. KraftIndependent Director | -6,47k | 3,47M | Derivative Exercise and Sale | 54,99 - 591,85 | 833,00 | - |
| 2025-11-14 | Dr. August James TroendleCEO, President & Chairman | -20,79k | 12,35M | Vente | 591,00 - 595,26 | 5,63M | -0,37% |
| 2025-11-12 | Dr. August James TroendleCEO, President & Chairman | -10,44k | 6,29M | Vente | 601,37 - 603,23 | 5,65M | -0,18% |
| 2025-11-11 | Ms. Susan E. BurwigExec. VP of Operations | -18,00k | 10,89M | Vente | 605,00 | 47,50k | -27,48% |
| 2025-11-05 | Mr. Jesse J. GeigerInitié | -21,50k | 12,81M | Automatic Disposition | 595,66 | 15,00k | -58,91% |
| 2025-10-30 | Mr. Fred B. DavenportLead Independent Director | 500,00 | 27,50k | Derivative Exercise and Retained Stock | 54,99 | 5,50k | 10,00% |
| 2025-10-30 | Mr. Fred B. DavenportLead Independent Director | -5,97k | 3,15M | Derivative Exercise and Sale | 54,99 - 581,88 | 5,50k | - |
| 2025-10-27 | Mr. Jesse J. GeigerInitié | -23,03k | 10,02M | Derivative Exercise and Sale | 166,73 - 605,12 | 36,50k | - |
| 2025-10-27 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | 3,00k | 500,19k | Derivative Exercise and Retained Stock | 166,73 | 13,34k | 29,01% |
| 2025-10-27 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | -15,23k | 6,58M | Derivative Exercise and Sale | 166,73 - 598,85 | 13,34k | - |
| 2025-10-27 | Ms. Susan E. BurwigExec. VP of Operations | -2,00k | 1,21M | Vente | 605,01 | 65,50k | -2,96% |
| 2025-09-30 | Mr. Robert O. KraftIndependent Director | 57,00 | 0,00 | Derivative Exercise and Retained Stock | - | 833,00 | 7,35% |
| 2025-09-30 | Mr. Cornelius Patrick McCarthyIndependent Director | 49,00 | 0,00 | Derivative Exercise and Retained Stock | - | 10,25k | 0,48% |
| 2025-09-30 | Mr. Brian T. CarleyIndependent Director | 62,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,22k | 0,24% |
| 2025-09-26 | Ms. Susan E. BurwigExec. VP of Operations | 10,00k | 1,08M | Derivative Exercise and Retained Stock | 107,93 | 67,50k | 17,39% |
| 2025-09-03 | Ms. Susan E. BurwigExec. VP of Operations | -10,00k | 4,80M | Vente | 480,00 | 57,50k | -14,81% |
| 2025-08-29 | Dr. August James TroendleCEO, President & Chairman | -37,39k | 17,79M | Vente | 475,11 - 475,90 | 5,66M | -0,66% |
| 2025-08-27 | Dr. August James TroendleCEO, President & Chairman | -620,00 | 294,50k | Vente | 475,00 | 5,70M | -0,01% |
| 2025-08-26 | Ms. Susan E. BurwigExec. VP of Operations | 10,00k | 1,08M | Derivative Exercise and Retained Stock | 107,93 | 67,50k | 17,39% |
| 2025-08-19 | Mr. Cornelius Patrick McCarthyIndependent Director | -1,66k | 772,90k | Vente | 465,04 | 10,20k | -14,01% |
| 2025-07-28 | Mr. Stephen P. EwaldCCO, General Counsel & Corporate Secretary | -3,00k | 1,35M | Vente | 450,00 | 10,34k | -22,48% |
| 2025-07-28 | Ms. Susan E. BurwigExec. VP of Operations | -7,50k | 3,38M | Vente | 450,14 | 57,50k | -11,54% |
| 2025-07-28 | Dr. August James TroendleCEO, President & Chairman | -48,49k | 21,90M | Vente | 451,69 | 5,70M | -0,84% |
| 2025-07-24 | Mr. Jesse J. GeigerInitié | -41,80k | 14,43M | Derivative Exercise and Sale | 107,93 - 453,11 | 36,50k | - |
| 2025-07-24 | Mr. Kevin M. BradyCFO & Treasurer | -12,00k | 4,76M | Derivative Exercise and Sale | 57,94 - 454,23 | 6,00k | - |
| 2025-07-22 | Mr. Cornelius Patrick McCarthyIndependent Director | 1,97k | 108,44k | Derivative Exercise and Retained Stock | 54,99 | 11,86k | 19,95% |
| 2025-07-18 | Mr. Cornelius Patrick McCarthyIndependent Director | 4,50k | 247,46k | Derivative Exercise and Retained Stock | 54,99 | 9,89k | 83,53% |
| 2025-06-30 | Mr. Cornelius Patrick McCarthyIndependent Director | 50,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,39k | 0,94% |
| 2025-06-30 | Mr. Robert O. KraftIndependent Director | 57,00 | 0,00 | Derivative Exercise and Retained Stock | - | 776,00 | 7,93% |
| 2025-06-30 | Mr. Brian T. CarleyIndependent Director | 62,00 | 0,00 | Derivative Exercise and Retained Stock | - | 26,16k | 0,24% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
